申请人:BAYER PHARMA AKTIENGESELLSCHAFT
公开号:US20160263122A1
公开(公告)日:2016-09-15
The present invention relates to substituted N-(phenyl-heteroaryl)-3-acetylamino-benzamides and N-[3-(acetylamino)phenyl]-phenyl-heteroaryl-carboxamides of general formula (I) as described and defined herein, to methods of preparing said compounds, to intermediate compounds useful for preparing said compounds, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease such as cancer, wherein i.a.: L
A
represents an optionally substituted methylene or ethylene group; L
B
represents —N(H)—C(═0)- or —C(═0)—N(H)—; R
1
represents an optionally substituted 5- to 8-membered heterocycloalkyl, 4- to 10-membered heterocycloalkenyl, aryl, heteroaryl or —N(R7)(Ci-C6-alkyl) group; R
2
represents an optionally substituted 5- or 6-membered heteroaryl group; R
3
represents an optionally substituted phenyl group.
本发明涉及一般式(I)所描述和定义的取代N-苯基-杂环基-3-乙酰氨基苯甲酰胺和N-[3-(乙酰氨基)苯基]-苯基-杂环基-羧酰胺,以制备该化合物的方法,用于制备该化合物的中间体化合物,包含该化合物的制药组合物和组合物,以及用于制造治疗或预防癌症等疾病的制药组合物的使用,其中:LA表示可选择取代的亚甲基或乙烯基;LB表示-N(H)-C(═0)-或-C(═0)-N(H)-;R1表示可选择取代的5-至8-成员杂环烷基,4-至10-成员杂环烷基烯基,芳基,杂环芳基或-N(R7)(Ci-C6-烷基)基团;R2表示可选择取代的5-或6-成员杂环基团;R3表示可选择取代的苯基团。